Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jun 11, 14:34

Assessing Vir Biotechnology (VIR) Valuation As Timothy Coughlin Takes Board And Audit Committee Roles

Vir Biotechnology Inc
Webhose 2026 Jun 11, 12:47

Morgan Stanley Raises Vir Biotechnology (NASDAQ:VIR) Price Target to $27.00

Vir Biotechnology Inc
Webhose 2026 Jun 10, 20:05

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors | Morningstar

Vir Biotechnology Inc
Webhose 2026 Jun 10, 07:50

WINTON GROUP Ltd Buys 131,555 Shares of Vir Biotechnology, Inc. $VIR - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 07, 20:14

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?

Vir Biotechnology Inc
Webhose 2026 Jun 07, 15:16

Does Vir Biotechnology (VIR) Board Shuffle Hint At A Deeper Shift Toward Oncology?

Vir Biotechnology Inc
Webhose 2026 Jun 05, 03:55

Vir Biotechnology (NASDAQ:VIR) Director Sells $30,240.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 05, 00:12

Reviewing Beam Therapeutics (NASDAQ:BEAM) & Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 04, 00:20

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 15:00

VIR Maintained by Leerink Partners -- Price Target Raised to $21

Vir Biotechnology Inc
Webhose 2026 Jun 03, 14:41

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00

Vir Biotechnology Inc
Webhose 2026 Jun 03, 07:41

Leerink Partners Forecasts Strong Price Appreciation for Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 May 28, 08:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2026 May 28, 08:09

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2026 May 27, 11:07

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 May 25, 00:20

Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership

Vir Biotechnology Inc
Webhose 2026 May 18, 21:30

VIR: Vir Biotechnology Prepares to Present Trial Data at EASL Congress 2026

Vir Biotechnology Inc
Webhose 2026 May 18, 15:19

Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million

Vir Biotechnology Inc
Webhose 2026 May 15, 10:49

Vanguard Group Inc. Reduces Stock Position in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc

VirBiotechnology News

Emma Rose 2026 Jun 13, 00:00

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Sophia Claire 2026 Jun 13, 00:00

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Emma Rose 2026 Jun 13, 00:00

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Sophia Claire 2026 Jun 13, 00:00

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Emma Rose 2026 Jun 13, 00:00

US Stock Market Volatility Surges as Trading Logic Breaks Down

Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks
Julian Parker 2026 Jun 09, 16:02

US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets

commodity
Ghko B 2026 Jun 07, 16:01

CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts

cfd trading
Ghko B 2026 Jun 07, 16:01

A CFD Trading Guide for South Africa: Can ZA CFD Traders Profit from the FIFA World Cup Market Effect?

cfd trading
Vance X 2026 Jun 07, 16:00

What Is NFP in Trading? How to Trade the Nonfarm Payroll Report

Latest news

Show more
Sophia Claire 2026 Jun 13, 00:00

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Emma Rose 2026 Jun 13, 00:00

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Liam James 2026 Jun 13, 00:00

Global Market Snapshot: Key Events and Analysis of Financial Markets

Noah Lee 2026 Jun 13, 00:00

BoJ Policy Meeting Under Scrutiny Amid Governor's Health, Rate Hike Expectations

Emma Rose 2026 Jun 13, 00:00

US-Iran Standoff: Peak Pressure Tactics Amidst Hopes for a Diplomatic Breakthrough

Noah Lee 2026 Jun 13, 00:00

US Strategy on Hormuz Strait: Will Capturing Kharg Island Backfire?

Liam James 2026 Jun 13, 00:00

NATO Security Posture and US Military Adjustments: Divergent Risk Assessments Between the US and Europe

Sophia Claire 2026 Jun 13, 00:00

Hormuz Strait Shipping Landscape Shifts Amidst Easing Tensions and Strategic Maneuvers

Info

Spread

0.07

Spread (%)

0.8159 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1436914816

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.13

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 11, 16:04

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker 2026 Jun 11, 16:02

What Happens on the Day of an IPO?

Julian Parker 2026 Jun 10, 16:04

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Trustpilot